DUSTIN DENICOLA: Open Payments
NPI 1073879508 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,157 in 154 payments from 43 companies in 2025. Trend: 2023 $2,516 · 2024 $3,296 · 2025 $3,157
Food & beverage: $3,157
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $387 |
| Janssen Biotech, Inc. | 12 | $246 |
| Novartis Pharmaceuticals Corporation | 12 | $241 |
| Daiichi Sankyo Inc. | 10 | $217 |
| ABBVIE INC. | 6 | $208 |
| Merck Sharp & Dohme LLC | 8 | $169 |
| Incyte Corporation | 9 | $153 |
| Celgene Corporation | 7 | $130 |
| Regeneron Healthcare Solutions, Inc. | 5 | $125 |
| PFIZER INC. | 6 | $109 |
Products named: REBLOZYL, Enhertu, IMFINZI, KISQALI, LINZESS, TALVEY, DATROWAY, JAKAFI.
Industry payments across LA — which companies pay providers there.
